Andrew Wasson

Andrew Wasson is a partner in the firm’s New York office, the chair of the firm’s FDA practice, and a member of the Executive Committee.  Andrew’s practice involves patent litigation in Federal district court and appellate court proceedings, post-grant patent proceedings, due diligence, and long-term patent portfolio strategy.  Andrew’s experience includes pharmaceuticals, biologics, and medical devices in a variety of therapeutic areas (e.g., central nervous system disorders, critical care, ophthalmology, dermatology, oncology, women’s health, and rare diseases) and with a variety of delivery technologies (e.g. extended release, topical, transdermal, injectable, and percutaneous).  Andrew serves as a member of the Food & Drug Law Journal’s editorial advisory board and has served as an Adjunct Lecturer of Entrepreneurship & Innovation at Iona University.